| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2012-06-20 | Sartorius Stedim Biotech (Germany) Bosch Packaging Technology (Germany) | single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of drug products | services |
Services contract | ||
| 2012-06-19 | Epigenomics (Germany-USA) Companion Dx Reference Lab (USA) | DNA methylation biomarker septin9 | colorectal cancer | licensing |
Cancer - Oncology | Licensing agreement |
| 2012-06-19 | Roche (Switzerland) Seaside Therapeutics (USA) | mGluR5 antagonists including STX209 | fragile X syndrome (FXS), autism spectrum disorders (ASD) | R&D |
Genetic diseases - Rare diseases - CNS diseases - Neurodevelopmental diseases | R&D agreement |
| 2012-06-19 | Sanofi (France) Joslin Diabetes Center (USA) | new medicines for the treatment of diabetes and related metabolic disorders | diabetes and related metabolic disorders | R&D |
Metabolic diseases | R&D agreement |
| 2012-06-19 | AstraZeneca (UK) Rigel Pharmaceuticals (USA) | R256 (inhaled JAK inhibitor) | chronic asthma | licensing |
Respiratory diseases - Inflammatory diseases - Allergic diseases | Licensing agreement |
| 2012-06-19 | Biocartis (Belgium) Debiopharm (Switzerland) Immunexpress (Australia) | multiplex gene expression assay SeptiCyte® Triage | sepsis | licensing |
Infectious diseases | Licensing agreement |
| 2012-06-19 | Royal DSM (The Netherlands) undisclosed major pharmaceutical company | XD® high cell density process technology | manufacturing |
Production agreement | ||
| 2012-06-19 | Heptares Therapeutics (UK) Medical Research Council - MRC (UK) | G-protein coupled receptors (GPCRs), and other transmembrane proteins | R&D |
R&D agreement | ||
| 2012-06-18 | Bavarian Nordic (Denmark) National Institute of Allergy and Infectious Diseases (NIAID) (USA) | candidate vaccines | smallpox, infectious diseases, cancer | R&D development |
Infectious diseases - Cancer- Oncology | |
| 2012-06-18 | Debiopharm (Switzerland) Ascepion Pharmaceuticals (China) | ASP-08126 (Debio 1144) | cancer | licensing |
Cancer - Oncology | Licensing agreement |
| 2012-06-18 | KineMed (USA) GSK (UK) | kinetic biomarkers | muscle wasting, fibrosis, metabolic diseases | R&D |
Metabolic diseases - Neuromuscular diseases | R&D agreement |
| 2012-06-18 | Epicept (USA) Meda (Sweden) | Ceplene® (histamine dihydrochloride) | acute myeloid leukemia | product acquisition |
Cancer - Oncology | Product acquisition |
| 2012-06-18 | Zealand Pharma (Denmark) Protagonist Therapeutics (USA) | novel disulfide rich peptides (DRPs) | undisclosed | R&D |
undisclosed | R&D agreement |
| 2012-06-18 | D3 Pharma (UK) Encap Drug Delivery (UK) | Plenachol™ (vitamin D3) | vitamin D deficiency and insufficiency | manufacturing |
Metabolic diseases | Production agreement |
| 2012-06-18 | Alsace BioValley (France) CQDM (Canada) Lyonbiopole (France) | R&D |
R&D agreement | |||
| 2012-06-18 | GSK (UK) University of Cambridge (UK) | R&D |
R&D agreement | |||
| 2012-06-15 | Oncoethix (Switzerland) Mitsubishi Tanabe Pharma (Japan) | OTX015 | licensing |
Cancer - Oncology | Licensing agreement | |
| 2012-06-14 | BioGenes (Germany) Boehringer Ingelheim (Germany) | host cell protein (HCP) assays for late stage drug substances | services |
Services contract | ||
| 2012-06-14 | Medigene (Germany) Azanta (Denmark) | Veregen® ointment (made from the extract of green tea leaves - catechins) | genital and perianal wart | supply |
Infectious diseases - Gynecology - Women's health | Commercialisation agreement |
| 2012-06-13 | Novo Nordisk (Denmark) JDRF - Juveniles Diabetes Research Foundation (USA) | novel immunotherapies and especially auto antigen-specific immunotherapies | type 1 diabetes | R&D |
Metabolic diseases | R&D agreement |
